Immunomedics (IMMU) Says Revised Settlement Offer Rejected By venBio

March 2, 2017 10:24 AM EST Send to a Friend
Immunomedics, Inc. (NASDAQ: IMMU) today announced that the Company offered venBio Select Advisor, LLC ("venBio") a revised settlement proposal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login